Mechanism of Action
Actin Sequestration & Cell Migration
Modulation of cytoskeletal actin dynamics to enhance cell migration, angiogenesis, and tissue regeneration.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
Compounds
1
Total studies
119
Human studies
4
FDA approved
0
Overview
Actin-sequestering peptides bind G-actin monomers, regulating the polymerization-depolymerization cycle of the cytoskeleton. This modulates cell migration, endothelial tube formation, and stem-cell recruitment to injury sites. The pathway is critical for wound repair, cardiac tissue regeneration, and anti-inflammatory cell migration.
Actin dynamics regulate virtually every aspect of cell migration, from lamellipodial extension to contractile force generation. Thymosin beta-4 is the most abundant G-actin sequestering protein in mammalian cells and maintains a monomeric actin pool available for rapid polymerization at the leading edge. TB-500, a synthetic fragment of thymosin beta-4, recapitulates many of the parent protein's effects in animal models of wound healing and cardiac ischemia. Clinical trials have explored TB-500 in cardiac ischemia and epidermolysis bullosa with mixed results.
Receptor & signaling detail
Thymosin beta-4 does not act through a single conventional receptor. Its primary known interaction is with G-actin through a defined binding motif. Additional receptor-mediated effects (via surface receptors including ILK-related complexes) have been proposed but remain incompletely characterized.
How it works
- 1Binds G-actin monomers, regulating actin filament assembly.
- 2Modulates cytoskeletal dynamics to enable cell migration.
- 3Upregulates VEGF and promotes angiogenesis.
- 4Recruits progenitor stem cells to injured tissue.
- 5Downregulates inflammatory cytokines.
Downstream clinical effects
- Enhanced wound re-epithelialization
- Cardiac tissue repair (preclinical)
- Hair follicle stem-cell activation
- Reduced scar formation
Documented clinical implications
- Enhanced wound re-epithelialization in animal models
- Cardiac tissue repair benefits in preclinical ischemia-reperfusion models
- Hair follicle stem-cell activation (topical research)
- Reduced scar formation in some experimental systems
Limitations & mechanism-driven side effects
- Most evidence is preclinical — controlled human trial data is thin
- Not FDA approved for any indication
- WADA prohibited in athletic contexts
- Cost and availability through compounding pharmacies is uncertain given regulatory scrutiny
Discovery & development
Thymosin beta-4 was isolated in 1981 from the thymus. TB-500 — a specific subset of the parent peptide — was developed as a synthetic fragment for research use in the 2000s.
Peptides using this mechanism
Evidence status
TB-500 / Thymosin Beta-4 has strong preclinical data. Human trials in cardiac ischemia and epidermolysis bullosa are ongoing.
Frequently asked questions
What is the difference between TB-500 and thymosin beta-4?
Thymosin beta-4 is the full-length 43-amino-acid protein. TB-500 refers to a specific synthetic sequence derived from a region of the parent protein and is a different molecule despite the commercial overlap in naming.
Why is TB-500 stacked with BPC-157?
The stack combines BPC-157's angiogenic effects with TB-500's cell-migration effects — complementary mechanisms on paper. The combination has not been studied in controlled human trials.
Is TB-500 safe?
Human safety data is limited. Preclinical studies have not flagged specific toxicity, but long-term safety in human use is not established.
Is TB-500 WADA banned?
Yes. TB-500 is prohibited by WADA under the S2 (peptide hormones, growth factors, and related substances) category.
Relevant best-of guides
Best Peptides for Muscle Recovery & Injury Healing
Peptides most studied for tissue repair, tendon healing, and post-exercise recovery — ranked by the quality of supporting research.
Best Peptides for Athletic Performance
Peptides associated with athletic performance contexts — ranked by evidence and WADA status.
Related articles
FDA Sets July 23–24 Meeting to Review BPC-157, TB-500, and 5 More Peptides for Compounding Access
Regulatory · 12 min
RFK Jr. Announces 14 Peptides Moving Back to Category 1: What It Means
Regulatory · 7 min
FDA Category 2 Peptide Ban: The Complete Guide
Regulatory · 7 min
BPC-157 Human Clinical Data: Where We Stand in 2026
Research · 6 min
BPC-157 vs TB-500: Recovery Peptides Compared
Comparison · 10 min